Open Access Journals - Health Science - Acta Pharmaceutica

Permanent URI for this collection

http://repository.vlu.edu.vn:443/handle/123456789/9351

Browse

Recent Submissions

Now showing 1 - 1 of 1
  • Publication
    Acta Pharmaceutica Volume 73
    ( 2023)
    (Xanthoxyletin blocks the RANK/RANKL signaling pathway to suppress the growth of human pancreatic cancer cells - https://doi.org/10.2478/acph-2023-0024) - (A novel 4-(1,3,4-thiadiazole-2-ylthio)pyrimidine derivative inhibits cell proliferation by suppressing the MEK/ERK signaling pathway in colorectal cancer - https://doi.org/10.2478/acph-2023-0025) - (Scoulerine promotes cytotoxicity and attenuates stemness in ovarian cancer by targeting PI3K/AKT/mTOR axis - https://doi.org/10.2478/acph-2023-0021) - (Formulation and optimization of polymeric nanoparticles loaded with riolozatrione: a promising nanoformulation with potential antiherpetic activity - https://doi.org/10.2478/acph-2023-0028) - (Design and synthesis of amino-substituted N-arylpiperidinyl- -based inhibitors of the (immuno)proteasome - https://doi.org/10.2478/acph-2023-0032) - (Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts through regulation of the HOXA6/ZBTB12 axis - https://doi.org/10.2478/acph-2023-0033) - (Influence of fused deposition modelling printing parameters on tablet disintegration times: a design of experiments study - https://doi.org/10.2478/acph-2023-0026) - (Insights into the formulation properties, biocompatibility, and permeability of poorly water-soluble methoxyflavones with PEG400 and propylene glycol - https://doi.org/10.2478/acph-2023-0030) - (Rosuvastatin effects on the HDL proteome in hyperlipidemic patients - https://doi.org/10.2478/acph-2023-0034)